SCHEMBL3573137

SCHEMBL3573137

CC(=O)Nc1c(Cl)cc(Cl)c(F)c1C(=O)N(CCc1cccc(C(F)(F)F)c1)Cc1ccc(C2CC2)cc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.35
CNR1 P21554 1/20 0.34
DCUN1D1 Q96GG9 8/20 0.33
UBE2M P61081 6/20 0.33
MCHR1 Q99705 1/20 0.33
PIM1 P11309 1/20 0.33
PDGFRA P16234 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR5 Q9H228 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HPGD P15428 1/20 0.33
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3584408 0.92 MEN1 (0.39) LMNACNR1DCUN1D1UBE2MS1PR1
SCHEMBL3583120 0.87 GRM2 (0.37) LMNACNR1DCUN1D1UBE2MPIM1
SCHEMBL3580280 0.83 DCUN1D1 (0.36) LMNACNR1DCUN1D1UBE2MS1PR1
SCHEMBL3576637 0.83 LMNA (0.41) LMNACNR1PIM1PDGFRAS1PR1
SCHEMBL3586114 0.82 LMNA (0.41) LMNACNR1MEN1CYP1A2CYP3A4
SCHEMBL3581091 0.80 STAT3 (0.39) CNR1DCUN1D1UBE2MMCHR1
SCHEMBL3583574 0.80 HSD11B1 (0.34) LMNADCUN1D1UBE2MS1PR1S1PR5
SCHEMBL27730361 0.79 LMNA (0.33) LMNACNR1MCHR1MEN1CYP1A2
SCHEMBL3574585 0.78 LMNA (0.42) LMNACNR1PIM1PDGFRAS1PR1
SCHEMBL3573419 0.78 GRM2 (0.39) LMNADCUN1D1UBE2MS1PR1S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678818-B2 Anthranilamide and 2-amino-heteroarene-carboxamide compounds HOFFMANN-LA ROCHE INC. (US) 2010-03-16 US claimed
EP-1984340-B1 ANTHRANILAMIDE/2-AMINO-HETEROARENE CARBOXAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2012-06-27 EP disclosed